Adaptyv

Adaptyv Bio is a Swiss biotechnology company specializing in high-throughput protein engineering and design. The company operates a "protein foundry" that integrates synthetic biology, microfluidics, and machine learning to rapidly synthesize and characterize thousands of new protein variants. By automating the design-build-test cycle, Adaptyv Bio enables the development of novel therapeutics, including optimized antibodies and enzymes, with significantly reduced timelines. Their platform aims to bridge the gap between computational protein design and experimental validation, providing high-quality data to train generative AI models for biology. The company's technology is designed to support the next generation of protein-based medicines by making experimental feedback loops faster and more scalable.